(MENAFN- America News Hour) Heparin market report which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market.
Heparin Market Statistics –
USD 10 billion revenue in 2022 The market size is projected to record a valuation of over USD 15 billion by 2035 The membrane filtration industry is slated to observe 4% growth rate through 2023-2035
Get Your Free Sample Copy of this Report @
According to the statistics by the World Bank, the current healthcare expenditure as a share of GDP around the globe increased from 9.417% in 2013 to 9.857% in 2018.
Globally, the expenditure on health, both from the government of nations as well as the out-of-pocket expenditure by individuals, has increased massively around the globe. This, as a result, is driving the research and advancements in the field of healthcare, especially in the development of advanced drugs that can diagnose, treat or cure different diseases. On the other hand, with the growing incidences of venous thromboembolism worldwide, there is a growing need for anticoagulants, such as heparin, which is expected to drive the market growth in the coming years.
The U.S. Centers for Disease Control and Prevention (CDC), in one of its statistics, stated that around 60,000-100,000 Americans die of deep vein thrombosis/pulmonary embolism (DVT/PE). Further, it also stated that within 10 years, 1/3rd
of the people with DVT/PE would have a recurrence of the disease.
Such factors are expected to drive the growth of the global heparin market in the coming years.
According to recent study by Research Nester, the Heparin Market size is anticipated to surpass USD 15 Bn by 2035 and is projected to expand at CAGR of over 4% from 2022 to 2035.
Major players include in the Global Heparin Market:
Aspen Holdings Company Overview Business Strategy Key Product Offerings Financial Performance Key Performance Indicators Risk Analysis Recent Development Regional Presence SWOT Analysis
Opocrin S.p.A. LEO Pharma Inc. Baxter Dr. Reddy's Laboratories Ltd. Pfizer Inc. B. Braun Medical Inc. Bioiberica S.A.U. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Fresenius Kabi Canada
Get Your Free Sample Copy of this Report @
The global heparin market is also segmented on the basis of geography into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of the markets in these regions, the market in North America region garnered the largest revenue of USD 2188.2 Million in 2020, and is further anticipated to hold the highest market share throughout the forecast period and attain a revenue of USD 3270.7 Million by the end of 2035. The market in the region is also anticipated to grow with a CAGR of 4.1% during the forecast period.
However, the increasing adoption of oral anticoagulants, such as warfarin, is one of the major factors anticipated to hamper the market growth.
This report also provides the existing competitive scenario of some of the key players of the global heparin market, which includes company profiling of GlaxoSmithKline plc, Pfizer Inc., Aspen Holdings, Baxter International Inc., Fresenius Kabi AG, Amphastar Pharmaceuticals, Inc., Mylan N.V., Sanofi, LEO Pharma A/S, B.Braun Melsungen AG, and others.
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.